Unlike full-length growth hormone, which can cause edema (fluid retention), joint pain, carpal tunnel syndrome, glucose elevation, and increased IGF-1, AOD-9604 demonstrates none of these effects in clinical trials
Fernandes Gomes B, Kumar A, Ashton NJ et al (2024) Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders
While rare, hypopigmentation (light spots) or hyperpigmentation (dark spots) can occur, especially in darker skin tones
These findings are consistent with improvement in cognitive performance and BPSD in prior placebo-controlled studies with NF, and contrast with the routine decline for participants receiving placebo. Cuturic, M, et al Clinical outcomes and low-dose levocarnitine supplementation in psychiatric inpatients with documented hypocarnitinemia: a retrospective chart review. in Journal of Psychiatric Practice
Both assays rely on measuring the rate of cytochrome c reduction in terms of changes in cytochrome c absorbance, which is typically reduced by complex III
